Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 12623 / DOSAGE - TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| METRONIDAZOLE(UNII: 140QMO216E) (METRONIDAZOLE - UNII:140QMO216E) | METRONIDAZOLE | 500mg | 250mg |
Inactive Ingredients
| Ingredient Name | G.D. Searle LLC Division of Pfizer Inc |
|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |
| POWDERED CELLULOSE(SMD1X3XO9M) | |
| STEARIC ACID(4ELV7Z65AP) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
